Rhinovirus (RV) infections account for most asthma exacerbations among children and adults, yet the fundamental mechanism responsible for why asthmatics are more susceptible to RV than otherwise healthy individuals remains largely unknown. Nonetheless, the use of models to understand the mechanisms of RV-induced airway disease in asthma has dramatically expanded our knowledge about the cellular and molecular pathogenesis of the disease. For instance, ground-breaking studies have recently established that the susceptibility to RV in asthmatic subjects is associated with a dysfunctional airway epithelial inflammatory response generated after innate recognition of viral-related molecules, such as double-stranded RNA. This review summarizes the novel cardinal features of the asthmatic condition identified in the past few years through translational and experimental RV-based approaches. Specifically, we discuss the evidence demonstrating the presence of an abnormal innate antiviral immunity (airway epithelial secretion of types I and III interferons), exaggerated production of the master Th2 molecule thymic stromal lymphopoietin, and altered antimicrobial host defense in the airways of asthmatic individuals with acute RV infection.
JacksonDJ, GangnonRE, EvansMD. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med. 2008; 178(7): 667–672.
3.
CalışkanM, BochkovYA, Kreiner-MøllerE. Rhinovirus wheezing illness and genetic risk of childhood-onset asthma. N Engl J Med. 2013; 368(15): 1398–1407.
4.
KennedyJL, ShakerM, McMeenV. Comparison of viral load in individuals with and without asthma during infections with rhinovirus. Am J Respir Crit Care Med. 2014; 189(5): 532–539.
5.
SabaTG, ChungY, HongJY. Rhinovirus-induced macrophage cytokine expression does not require endocytosis or replication. Am J Respir Cell Mol Biol. 2014; 50(5): 974–984.
JacksonDJ, EvansMD, GangnonRE. Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life. Am J Respir Crit Care Med. 2012; 185(3): 281–285.
8.
LeeWM, LemanskeRFJr, EvansMD. Human rhinovirus species and season of infection determine illness severity. Am J Respir Crit Care Med. 2012; 186 (9): 886–891.
9.
WangQ, NagarkarDR, BowmanER. Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses. J Immunol. 2009; 183(11): 6989–6997.
10.
WarkPA, JohnstonSL, BucchieriF. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med. 2005; 201(6): 937–947.
11.
UllerL, LeinoM, BedkeN. Double-stranded RNA induces disproportionate expression of thymic stromal lymphopoietin versus interferon-beta in bronchial epithelial cells from donors with asthma. Thorax. 2010; 65(7): 626–632.
12.
LewisTC, HendersonTA, CarpenterAR. Nasal cytokine responses to natural colds in asthmatic children. Clin Exp Allergy. 2012; 42(12): 1734–1744.
13.
ProudD, TurnerRB, WintherB. Gene expression profiles during in vivo human rhinovirus infection: insights into the host response. Am J Respir Crit Care Med. 2008; 178(9): 962–968.
14.
TatematsuM, SeyaT, MatsumotoM. Beyond dsRNA: Toll-like receptor 3 signalling in RNA-induced immune responses. Biochem J. 2014; 458(2): 195–201.
15.
IvashkivLB, DonlinLT. Regulation of type I interferon responses. Nat Rev Immunol. 2014; 14(1): 36–49.
16.
YooJK, KimTS, HuffordMM. Viral infection of the lung: host response and sequelae. J Allergy Clin Immunol. 2013; 132(6): 1263–1276.
17.
ChenG, KorfhagenTR, KarpCL. Foxa3 induces goblet cell metaplasia and inhibits innate antiviral immunity. Am J Respir Crit Care Med. 2014; 189(3): 301–313.
18.
PillaiDK, SankoorikalBJ, JohnsonE. Directional secretomes reflect polarity-specific functions in an in vitro model of human bronchial epithelium. Am J Respir Cell Mol Biol. 2014; 50(2): 292–300.
19.
DvorakA, TilleyAE, ShaykhievR. Do airway epithelium air-liquid cultures represent the in vivo airway epithelium transcriptome?Am J Respir Cell Mol Biol. 2011; 44(4): 465–473.
20.
WangQ, MillerDJ, BowmanER. MDA5 and TLR3 initiate pro-inflammatory signaling pathways leading to rhinovirus-induced airways inflammation and hyperresponsiveness. PLoS Pathog. 2011; 7(5): e1002070.
21.
SlaterL, BartlettNW, HaasJJ. Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium. PLoS Pathog. 2010; 6(11): e1001178.
22.
SpannKM, BaturcamE, SchagenJ. Viral and host factors determine innate immune responses in airway epithelial cells from children with wheeze and atopy. Thorax. 2014; 69(20): 928–925.
23.
ParsonsKS, HsuAC, WarkPA. TLR3 and MDA5 signalling, although not expression, is impaired in asthmatic epithelial cells in response to rhinovirus infection. Clin Exp Allergy. 2014; 44(1): 91–101.
24.
MalliaP, MessageSD, GielenV. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med. 2011; 183(6): 734–742.
25.
ContoliM, MessageSD, Laza-StancaV. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med. 2006; 12(9): 1023–1026.
26.
SykesA, EdwardsMR, MacintyreJ. Rhinovirus 16-induced IFN-α and IFN-β are deficient in bronchoalveolar lavage cells in asthmatic patients. J Allergy Clin Immunol. 2012; 129(6): 1506–1514.
27.
BaraldoS, ContoliM, BazzanE. Deficient antiviral immune responses in childhood: distinct roles of atopy and asthma. J Allergy Clin Immunol. 2012; 130(6): 1307–1314.
28.
MillerEK, HernandezJZ, WimmenauerV. A mechanistic role for type III IFN-λ1 in asthma exacerbations mediated by human rhinoviruses. Am J Respir Crit Care Med. 2012; 185(5): 508–516.
ChenZG, ZhangTT, LiHT. Neutralization of TSLP inhibits airway remodeling in a murine model of allergic asthma induced by chronic exposure to house dust mite. PLoS One. 2013; 8(1): e51268.
31.
Al ShamiA, SpolskiR, KellyJ. A role for TSLP in the development of inflammation in an asthma model. J Exp Med. 2005; 202(6): 829–839.
32.
ZhouB, ComeauMR, De SmedtT. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat Immunol. 2005; 6(10): 1047–1053.
33.
GauvreauGM, O'ByrnePM, BouletLP. Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N Engl J Med. 2014; 370(22): 2102–2110.
34.
Mahmutovic-PerssonI, AkbarshahiH, BartlettNW. Inhaled dsRNA and rhinovirus evoke neutrophilic exacerbation and lung expression of thymic stromal lymphopoietin in allergic mice with established experimental asthma. Allergy. 2014; 69(3): 348–358.
35.
NagarkarDR, BowmanER, SchneiderD. Rhinovirus infection of allergen-sensitized and -challenged mice induces eotaxin release from functionally polarized macrophages. J Immunol. 2010; 185(4): 2525–2535.
36.
PerezGF, PanchamK, HuseniS. Rhinovirus infection in young children is associated with elevated airway TSLP levels. Eur Respir J. 2014; 44(4): 1075–1078.
37.
EgeMJ, MayerM, NormandAC. Exposure to environmental microorganisms and childhood asthma. N Engl J Med. 2011; 364(8): 701–709.
38.
BeckJM, YoungVB, HuffnagleGB. The microbiome of the lung. Transl Res. 2012; 160(4): 258–266.
39.
DicksonRP, Erb-DownwardJR, HuffnagleGB. The role of the bacterial microbiome in lung disease. Expert Rev Respir Med. 2013; 7(3): 245–257.
40.
FrancisOE, BendallM, ManimaranS. Pathoscope: species identification and strain attribution with unassembled sequencing data. Genome Res. 2013; 23(10): 1721–1729.
41.
MolyneauxPL, MalliaP, CoxMJ. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013; 188(10): 1224–1231.
42.
MalliaP, FootittJ, SoteroR. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012; 186(11): 1117–1124.
43.
GeorgeSN, GarchaDS, MackayAJ. Human rhinovirus infection during naturally occurring COPD exacerbations. Eur Respir J. 2014; 44(1): 87–96.
44.
KloepferKM, LeeWM, PappasTE. Detection of pathogenic bacteria during rhinovirus infection is associated with increased respiratory symptoms and asthma exacerbations. J Allergy Clin Immunol. 2014; 133(5): 1301–1307.
45.
RohdeG, MessageSD, HaasJJ. CXC chemokines and antimicrobial peptides in rhinovirus-induced experimental asthma exacerbations. Clin Exp Allergy. 2014; 44(7): 930–939.
